David Wiseman, PhD is a research scientist who runs his own research and development consulting business, Synechion. His areas of expertise include pharmacy, pharmacology, and experimental pathology.
Wiseman lent his skills and expertise to numerous important scientific inquiries during the COVID-19 pandemic, including work on research into antiviral medications such as hydroxychloroquine and ivermectin.